Goodwin Procter LLP advised Checkmate Pharmaceuticals, Inc., while Latham & Watkins LLP represents the underwriters in the offering.Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) closed its initial public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
